Cargando…

PD-1 The impact of COVID-19 on diagnosis, stage and treatment of esophageal and gastric cancer

Detalles Bibliográficos
Autores principales:	Bakx, J., Doeve, B., Siersema, P., Rosman, C., Grieken, N., van Berge Henegouwen, M., van Sandick, J., Verheij, M., Bijlsma, M., Verhoeven, R., van Laarhoven, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250150/ http://dx.doi.org/10.1016/j.annonc.2022.04.079

Ejemplares similares

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer
por: Doeve, Benthe H., et al.
Publicado: (2023)

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer
por: van Velzen, Merel J. M., et al.
Publicado: (2023)

Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition
por: van den Ende, Tom, et al.
Publicado: (2023)

Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP)
por: Jezerskyte, E., et al.
Publicado: (2021)

Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit
por: Kalff, Marianne C., et al.
Publicado: (2021)

Towards Personalization in the Curative Treatment of Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2020)

Tumor‐immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas
por: Soeratram, Tanya TD, et al.
Publicado: (2021)

Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study
por: Besseling, Joost, et al.
Publicado: (2021)

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020)

Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial
por: Claassen, Y. H. M., et al.
Publicado: (2018)

A population-based study in resected esophageal or gastroesophageal junction cancer aligned with CheckMate 577
por: Pape, Marieke, et al.
Publicado: (2022)

Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis
por: van den Ende, Tom, et al.
Publicado: (2019)

The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
por: van Laarhoven, Hanneke W.M., et al.
Publicado: (2023)

Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study)
por: Brenkman, H. J. F., et al.
Publicado: (2018)

Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study
por: Seesing, M F J, et al.
Publicado: (2019)

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent
por: Haj Mohammad, N., et al.
Publicado: (2015)

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX
por: Stroes, Charlotte I., et al.
Publicado: (2021)

Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis
por: Creemers, A., et al.
Publicado: (2017)

Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
por: Keywani, Kammy, et al.
Publicado: (2023)

Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study
por: Voeten, Daan M., et al.
Publicado: (2021)

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2022)

The dynamics of HER2 status in esophageal adenocarcinoma
por: Creemers, Aafke, et al.
Publicado: (2018)

A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas
por: Creemers, Aafke, et al.
Publicado: (2018)

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
por: Goedegebuure, R.S.A., et al.
Publicado: (2021)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
por: Haj Mohammad, Nadia, et al.
Publicado: (2014)

Prevalence of nodal metastases in the individual lymph node stations for different T-stages in gastric cancer: a systematic review
por: de Jong, M. H. S., et al.
Publicado: (2022)

Severity of oEsophageal Anastomotic Leak in patients after oesophagectomy: the SEAL score
por: Ubels, Sander, et al.
Publicado: (2022)

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial
por: Slagter, Astrid E., et al.
Publicado: (2021)

Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
por: Biesma, Hedde D., et al.
Publicado: (2022)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
por: Dikken, Johan L, et al.
Publicado: (2011)

Length of hospital stay after uncomplicated esophagectomy. Hospital variation shows room for nationwide improvement
por: Voeten, Daan M., et al.
Publicado: (2020)

Long-Term Quality of Life Following Transthoracic and Transhiatal Esophagectomy for Esophageal Cancer
por: Jezerskyte, E., et al.
Publicado: (2020)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment
por: Fabbi, M, et al.
Publicado: (2020)

Evaluation of inter-user variability in indocyanine green fluorescence angiography to assess gastric conduit perfusion in esophageal cancer surgery
por: Hardy, Niall P, et al.
Publicado: (2022)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
por: Omloo, J. M. T., et al.
Publicado: (2011)

Health-Related Quality of Life in Locally Advanced Gastric Cancer: A Systematic Review
por: van Amelsfoort, Romy M., et al.
Publicado: (2021)

Unique case of esophageal rupture after a fall from height
por: van Heijl, Mark, et al.
Publicado: (2009)

Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands
por: Gertsen, Emma C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9lt16pmibeq84r730gab6fpnko